Commodore Capital LP’s Xenon Pharmaceuticals Inc Position
Does Commodore Capital LP own Xenon Pharmaceuticals Inc (XENE)? Yes — 825.0K shares worth $48M (+2.78% of its 13F portfolio) as of Q1 2026, down from 1.80M shares the prior filed quarter.
Position Value
$48M
Q1 2026
Shares
825.0K
% of Portfolio
+2.78%
Quarters Held
22
currently held
Position History XENE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 825.0K | $48M | +2.78% |
| Q4 2025 | 1.80M | $81M | +5.37% |
| Q3 2025 | 2.70M | $108M | +5.29% |
| Q2 2025 | 3.02M | $95M | +6.68% |
| Q1 2025 | 2.33M | $78M | +5.75% |
| Q4 2024 | 2.74M | $107M | +7.87% |
| Q3 2024 | 2.70M | $106M | +6.64% |
| Q2 2024 | 2.75M | $107M | +7.33% |
| Q1 2024 | 2.17M | $93M | +6.24% |
| Q4 2023 | 2.17M | $100M | +8.72% |
| Q3 2023 | 1.84M | $63M | +7.37% |
| Q2 2023 | 1.84M | $71M | +7.98% |
| Q1 2023 | 1.84M | $66M | +10.05% |
| Q4 2022 | 1.66M | $65,419 | +9.86% |
| Q3 2022 | 1.59M | $58M | +9.26% |
| Q2 2022 | 1.59M | $49M | +10.26% |
| Q1 2022 | 1.20M | $37M | +8.21% |
| Q4 2021 | 1.09M | $34M | +7.89% |
| Q3 2021 | 579.4K | $9M | +2.33% |
| Q2 2021 | 326.3K | $6M | +2.09% |
| Q1 2021 | 301.4K | $5M | +2.12% |
| Q4 2020 | 467.4K | $7M | +3.91% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Commodore Capital LP’s full portfolio or all institutional holders of XENE.